GFL
ABBV icon

Granite FO LLC’s AbbVie ABBV Stock Holding History

Granite FO LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-27
Closed -$5.28K – 50
2024
Q1 		$5.28K Hold
27
– – ﹤0.01% 134
2023
Q4 		$4.18K Hold
27
– – ﹤0.01% 148
2023
Q3 		$4.03K Hold
27
– – ﹤0.01% 153
2023
Q2 		$3.64K Sell
27
-86
-76% -$12.6K ﹤0.01% 162
2023
Q1 		$17.1K Buy
113
+26
+30% +$3.98K 0.01% 188
2022
Q4 		$14K Buy
+87
New +$13.3K 0.01% 121

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Granite FO LLC's ABBV Position: Q2 2024 in Review

Granite FO LLC sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 27 shares — an estimated $5.28K sold.

Granite FO LLC first reported a position in ABBV in Q4 2022 and held it in 6 quarters. The position peaked at $17.1K in Q1 2023. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • Granite FO LLC reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
  • Granite FO LLC sold 27 AbbVie shares in Q2 2024, an estimated $5.28K.
  • Granite FO LLC first reported a position in AbbVie in Q4 2022 and held it in 6 quarters.
  • Granite FO LLC's AbbVie position peaked at $17.1K in Q1 2023.
  • 3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Granite FO LLC's 13F filing for Q2 2024, filed 16 Aug 2024.